Biomana - Company finances
|
EUR
|
2020
From: 2020-08-28
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 0 | 802,573 | 1,002,191 | 1,390,596 | 1,345,831 | 485,526 |
| Profit before tax | 0 | - | - | - | - | - |
| Net profit | 0 | 104,739 | 77,268 | 119,993 | 29,454 | 22,713 |
| Equity | 2,500 | 107,239 | 184,507 | 304,499 | 304,541 | 126,900 |
| Liabilities | 0 | 118,027 | 9,642 | 8,338 | 69,949 | 62,346 |
| Non-current assets | 0 | 17,649 | 12,222 | 6,794 | 1,367 | 189,246 |
| Current assets | 2,500 | 207,617 | 181,927 | 306,043 | 373,123 | 0 |
| Total assets | 2,500 | 225,266 | 194,149 | 312,837 | 374,490 | 189,246 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | - | 7,965 | 28,713 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | +24.9% | +38.8% | -3.2% | -63.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 46.5% | 39.8% | 38.4% | 7.9% | 12.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 97.7% | 41.9% | 39.4% | 9.7% | 17.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 13.1% | 7.7% | 8.6% | 2.2% | 4.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 1.1 | 0.1 | 0.0 | 0.2 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 291,845 | 334,064 | 463,532 | 448,610 | 161,842 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biomana - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-08-17 | 2023-09-04 | 0.76 |
| 2023-07-26 | 2023-08-02 | 0.76 |
| 2023-07-24 | 2023-07-25 | 0.78 |
| 2023-06-16 | 2023-06-21 | 372.78 |
Biomana - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-27 | 2026-03-02 | 0.36 |
| 2026-02-21 | 2026-02-26 | 1453.57 |
| 2026-02-16 | 2026-02-20 | 1446.21 |
| 2025-05-17 | 2025-05-24 | 1.09 |
| 2025-05-09 | 2025-05-16 | 1.15 |
| 2025-04-28 | 2025-05-08 | 1.25 |
| 2025-04-06 | 2025-04-24 | 1.1 |
| 2025-04-04 | 2025-04-05 | 925.58 |
| 2025-04-03 | 2025-04-03 | 925.33 |
| 2025-04-02 | 2025-04-02 | 0.1 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biomana, UAB (code 305613227) is a Private Limited Liability Company engaged in the wholesale of other chemical products. In 2025, the company generated revenue of €485.5K and net profit of €22.7K, corresponding to a profit margin of 4.7%. This followed a weaker operating scale than in previous years: revenue fell from €1.39M in 2023 to €1.35M in 2024, and then declined sharply in 2025. Net profit also decreased from €120.0K in 2023 to €29.5K in 2024, before reaching €22.7K in 2025. Despite the lower turnover, profitability remained positive throughout the period. As of 2025, total assets stood at €189.2K, with equity of €126.9K and liabilities of €62.3K. The equity ratio was 67.1%, and debt-to-equity was 0.49. Asset turnover reached 2.57x, while ROE was 17.9% and ROA 12.0%. Revenue per employee was €161.8K, and profit per employee was €7.6K, indicating solid productivity relative to the company’s reduced 2025 revenue base.